Comparison of labetalol and propranolol in hypertension

British Journal of Clinical Pharmacology
D P NichollsA G Butler

Abstract

1 Labetalol has been compared with propranolol in a double-blind, double-dummy study of 24 patients with mild or moderate essential hypertension. 2 Two patients were unable to tolerate propranolol and five labetalol, because of symptom side effects; this difference was not significant (P greater than 0.1). 3 On a self-administered questionnaire, labetalol was associated with a greater number of side effects per patient than propranolol, but no individual side effect was significantly more common with either drug. 4 There was no difference in the number of spontaneously reported side effects between the two drugs. 5 Both drugs impaired pulmonary function, but propranolol caused a greater reduction than labetalol after 8 weeks of treatment. 6 We conclude that labetalol and propranolol are similarly effective and acceptable to the patient.

References

Jan 1, 1977·British Heart Journal·D A RichardsE J Knight
Aug 1, 1977·British Heart Journal·D W Barritt, A J Marshall
Aug 6, 1977·Lancet·A S HuaP Kincaid-Smith
Feb 25, 1978·Lancet·W J LouisF J Vajda
Apr 12, 1975·British Medical Journal·C SkinnerK N Palmer
Apr 1, 1978·British Medical Journal·R W Gange, E W Jones
Dec 18, 1978·European Journal of Clinical Pharmacology·G L SandersM D Rawlins
May 1, 1976·British Medical Journal·M H Frick, P Pörsti
May 6, 1972·Lancet·L J Beilin, B E Juel-Jensen
Aug 1, 1974·Journal of Chronic Diseases·C J BulpittS Carne
Sep 1, 1973·British Medical Journal·C J Bulpitt, C T Dollery
Jun 1, 1974·British Heart Journal·P A MajidS H Taylor
Sep 19, 1964·British Medical Journal·B N Prichard, P M GILLAM

Citations

Jan 1, 1984·European Journal of Clinical Pharmacology·M M Kubik, J H Coote
Jan 1, 1985·European Journal of Clinical Pharmacology·E D CookeA T Smith
Jan 1, 1983·Pharmacology & Therapeutics·A J Scriven, P J Lewis
Jan 27, 2018·The Cochrane Database of Systematic Reviews·Elizabeth N AllenKaren Barnes
Jan 1, 1982·Acta Medica Scandinavica. Supplementum·G Nyberg, G Berglund
Jan 1, 1982·Acta Medica Scandinavica. Supplementum·R A WalstadO G Nilsen

Related Concepts

Diastolic Blood Pressure
Clinical Trials
Double-Blind Method
Ethanolamines
Hypertensive Disease
Presolol
Rexigen

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Lipidomics & Rhinovirus Infection

Lipidomics can be used to examine the lipid species involved with pathogenic conditions, such as viral associated inflammation. Discovered the latest research on Lipidomics & Rhinovirus Infection.

Alzheimer's Disease: MS4A

Variants within the membrane-spanning 4-domains subfamily A (MS4A) gene cluster have recently been implicated in Alzheimer's disease in genome-wide association studies. Here is the latest research on Alzheimer's disease and MS4A.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Torsion Dystonia

Torsion dystonia is a movement disorder characterized by loss of control of voluntary movements appearing as sustained muscle contractions and/or abnormal postures. Here is the latest research.

Generating Insulin-Secreting Cells

Reprogramming cells or using induced pluripotent stem cells to generate insulin-secreting cells has significant therapeutic implications for diabetics. Here is the latest research on generation of insulin-secreting cells.

Central Pontine Myelinolysis

Central Pontine Myelinolysis is a neurologic disorder caused most frequently by rapid correction of hyponatremia and is characterized by demyelination that affects the central portion of the base of the pons. Here is the latest research on this disease.

Epigenome Editing

Epigenome editing is the directed modification of epigenetic marks on chromatin at specified loci. This tool has many applications in research as well as in the clinic. Find the latest research on epigenome editing here.